Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May;121(5):737-741.
doi: 10.1016/j.fertnstert.2024.02.029. Epub 2024 Feb 19.

Can we predict menopause and premature ovarian insufficiency?

Affiliations
Free article
Review

Can we predict menopause and premature ovarian insufficiency?

Joop S E Laven et al. Fertil Steril. 2024 May.
Free article

Abstract

The prediction of menopause and premature ovarian insufficiency (POI) involves understanding the factors that contribute to the timing of these events. Menopause is a natural biological process marked by the cessation of menstrual periods, typically occurring around the age of 51. On the other hand, POI refers to the loss of ovarian function before the age of 40. Several factors have been used to predict menopause and POI such as age, antimüllerian hormone, inhibins and follicle-stimulating hormone serum levels, antral follicle counts, menstrual cycle length, and, recently, some genetic markers. It seems that age has the best predictive power and all the other ones are only adding in a very limited way to the prediction of menopause. Low levels of antimüllerian hormone in young women might indicate a greater risk for POI and could facilitate early diagnosis. It is, however, important to note that predicting the exact timing of menopause and POI is challenging, and individual variations are significant. Although these factors can provide some insights, they are not foolproof predictors. Advances in medical research and technology may lead to more accurate methods for predicting menopause and POI in the future.

Keywords: AMH; Menopause; POI; age; genetics.

PubMed Disclaimer

Conflict of interest statement

Declaration of Interests J.S.E.L. reports grants from Ansh Labs, Webster, TX, USA; Ferring, Hoofddorp, NL; Dutch Heart Association, Utrecht, the Netherlands; Zon MW, Amsterdam, the Netherlands; Roche Diagnostics, Rothkreuz, Switzerland; and personal fees from Ferring, Hoofddorp, the Netherlands; Titus Healthcare, Hoofddorp, the Netherlands; Gedeon Richter, Groot-Bijgaarden, Belgium; and is an unpaid board member and president of the AE-PCOS Society, outside the submitted work. Y.V.L. has nothing to disclose.

LinkOut - more resources